1 Min Read
Aug 28 (Reuters) - Novo Nordisk A/S
* Health Canada approves Tresiba®, a new basal insulin for type 1 and 2 diabetes
* Novo Nordisk Canada Inc - Health Canada has approved Tresiba Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.